Abstract:Alternative splicing represents an essential process that occurs widely in eukaryotes. In humans, most genes undergo alternative splicing to ensure transcriptome and proteome diversity reflecting their functional complexity. Over the last decade, aberrantly spliced transcripts due to mutations in cis - or trans -acting splicing regulators have been tightly associated with cancer development, largely drawing scientific attention. Although a plethora of single proteins, ribonucleoproteins, complexed RNAs, and short RNA sequences have emerged as nodal contributors to the splicing cascade, the role of RNA secondary structures in warranting splicing fidelity has been underestimated. Recent studies have leveraged the establishment of novel high-throughput methodologies and bioinformatic tools to shed light on an additional layer of splicing regulation in the context of RNA structural elements. This short review focuses on the most recent available data on splicing mechanism regulation on the basis of RNA secondary structure, emphasizing the importance of the complex RNA G-quadruplex structures (rG4s), and other specific RNA motifs identified as splicing silencers or enhancers. Moreover, it intends to provide knowledge on newly established techniques that allow the identification of RNA structural elements and highlight the potential to develop new RNA-oriented therapeutic strategies against cancer.

Aberrant splicing in human cancer: An RNA structural code point of view

<scp>RNA</scp> structures in alternative splicing and back‐splicing

RNA Structures in Alternative Splicing and Back‐splicing

RNA structure in alternative splicing regulation: from mechanism to therapy

Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes

Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer

RNA splicing dysregulation and the hallmarks of cancer

Role of RNA Secondary Structures in Regulating Dscam Alternative Splicing

New insights into RNA secondary structure in the alternative splicing of pre-mRNAs

Alternative splicing and cancer: a systematic review

Dysregulation and therapeutic targeting of RNA splicing in cancer

The role of alternative splicing in human cancer progression.

Alternative Splicing in Myeloid Malignancies

Splicing-factor alterations in cancers

Aberrant Alternative Splicing in Breast Cancer

Mechanisms of non-coding RNA-modulated alternative splicing in cancer

Aberrant RNA Splicing As the Molecular Basis of Some Pathogenic Variants.

Conservation and Regulation of Alternative Splicing by Dynamic Inter- and Intra-Intron Base Pairings in Lepidoptera 14-3-3z Pre-Mrnas

Aberrant pre-mRNA processing in cancer

The interplay between non-coding RNAs and alternative splicing: from regulatory mechanism to therapeutic implications in cancer

Approaches to link RNA secondary structures with splicing regulation